Literature DB >> 17055406

Vector-based RNAi approaches for stable, inducible and genome-wide screens.

Gwen D Fewell1, Karin Schmitt.   

Abstract

RNA interference (RNAi) has revolutionized the study of biology and offers numerous applications in basic biology as well as in drug discovery research. Since the discovery of RNAi, several tools have been developed to enable loss-of-function studies in mammalian systems. The efficacy of RNAi is dependent on specific and versatile RNAi triggers that have evolved to enable transient, stable and in-vivo applications. Recently developed genome-wide short hairpin RNA (shRNA) and microRNA-adapted short hairpin RNA (shRNAmir) libraries incorporate advances in shRNA design and molecular 'barcodes' to enable more complex RNAi screens and the opportunity to progress to more complex genetics in whole animals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055406     DOI: 10.1016/j.drudis.2006.09.008

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  12 in total

1.  Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity.

Authors:  Qing Ge; Heini Ilves; Anne Dallas; Pavan Kumar; Joshua Shorenstein; Sergei A Kazakov; Brian H Johnston
Journal:  RNA       Date:  2009-12-01       Impact factor: 4.942

2.  Coenzyme Q10 rescues ethanol-induced corneal fibroblast apoptosis through the inhibition of caspase-2 activation.

Authors:  Chun-Chen Chen; Shiow-Wen Liou; Chi-Chih Chen; Wen-Chung Chen; Fung-Rong Hu; I-Jong Wang; Shing-Jong Lin
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

3.  Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases.

Authors:  Stefanie A Krumm; J Maina Ndungu; Jeong-Joong Yoon; Melanie Dochow; Aiming Sun; Michael Natchus; James P Snyder; Richard K Plemper
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

4.  Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs.

Authors:  Qing Ge; Anne Dallas; Heini Ilves; Joshua Shorenstein; Mark A Behlke; Brian H Johnston
Journal:  RNA       Date:  2009-11-30       Impact factor: 4.942

5.  Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.

Authors:  Lina Zhao; Yanglin Pan; Yi Gang; Honghong Wang; Haifeng Jin; Jun Tie; Lin Xia; Yongguo Zhang; Lijie He; Liping Yao; Taidong Qiao; Tingting Li; Zhiguo Liu; Daiming Fan
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

Review 6.  Systematic approaches towards the development of host-directed antiviral therapeutics.

Authors:  Andrew Prussia; Pahk Thepchatri; James P Snyder; Richard K Plemper
Journal:  Int J Mol Sci       Date:  2011-06-15       Impact factor: 5.923

7.  Caspase-2 mediated apoptotic and necrotic murine macrophage cell death induced by rough Brucella abortus.

Authors:  Fang Chen; Yongqun He
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

Review 8.  Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology.

Authors:  Maxwell C K Leung; Phillip L Williams; Alexandre Benedetto; Catherine Au; Kirsten J Helmcke; Michael Aschner; Joel N Meyer
Journal:  Toxicol Sci       Date:  2008-06-19       Impact factor: 4.849

Review 9.  Baculovirus-mediated gene delivery and RNAi applications.

Authors:  Kaisa-Emilia Makkonen; Kari Airenne; Seppo Ylä-Herttulala
Journal:  Viruses       Date:  2015-04-22       Impact factor: 5.048

10.  A modular lentiviral and retroviral construction system to rapidly generate vectors for gene expression and gene knockdown in vitro and in vivo.

Authors:  Benjamin Geiling; Guillaume Vandal; Ada R Posner; Angeline de Bruyns; Kendall L Dutchak; Samantha Garnett; David Dankort
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.